OTLKW
Outlook Therapeutics, Inc. - Se
1W: -12.0%
1M: -40.0%
3M: -82.9%
1Y: -97.0%
$0.03
Last traded 2022-02-16 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.01-0.035
Volume162,240
Avg Volume0
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEONone
SectorHealthcare
IndustryBiotechnology
IPO Date2016-06-20
Latest News
Outlook Therapeutics Announces Closing of $5.0 Million Public Offering
Outlook Therapeutics Announces Proposed Public Offering
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note
Outlook Therapeutics Provides Update Following Type A Meeting with FDA Regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg)
Recent Insider Trades
No insider trades found